EPAS1 and neoplasm: Whereas HIF-2α acts as a tumor suppressor in glioma, non-small cell lung cancer, and hepatocellular carcinoma [29–31], it drives tumorigenesis and growth of VHL-deficient renal clear-cell carcinoma [32].